| Accession Number: | 0001104659-21-116944 |
| Date: | 2021-09-17 |
| Issuer: | TYRA BIOSCIENCES, INC. (TYRA) |
| Original Submission Date: |
RA CAPITAL MANAGEMENT, L.P.
200 BERKELEY STREET
18TH FLOOR
BOSTON, MA 02116
RA CAPITAL HEALTHCARE FUND LP
C/O RA CAPITAL MANAGEMENT, L.P.
200 BERKELEY STREET, 18TH FLOOR
BOSTON, MA 02116
RA CAPITAL NEXUS FUND, L.P.
C/O RA CAPITAL MANAGEMENT, L.P.
200 BERKELEY STREET, 18TH FLOOR
BOSTON, MA 02116
KOLCHINSKY PETER
C/O RA CAPITAL MANAGEMENT, L.P.
200 BERKELEY STREET, 18TH FLOOR
BOSTON, MA 02116
SHAH RAJEEV M.
C/O RA CAPITAL MANAGEMENT, L.P.
200 BERKELEY STREET, 18TH FLOOR
BOSTON, MA 02116
| Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
|---|---|---|---|---|---|---|---|---|---|
| COMMON STOCK | 2021-09-17 | C | 4,047,120 | a | $0.00 | 4,047,120 | indirect | ||
| COMMON STOCK | 2021-09-17 | P | 1,250,000 | a | $16.00 | 5,297,120 | indirect | ||
| COMMON STOCK | 2021-09-17 | C | 1,496,613 | a | $0.00 | 1,496,613 | indirect | ||
| COMMON STOCK | 2021-09-17 | C | 442,721 | a | $0.00 | 442,721 | indirect |
| Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SERIES A PREFERRED STOCK | 0.0 | 2021-09-17 | deemed execution date | C | 1,011,370 (d) | common stock 2,626,932 | $0.00 | 0 | indirect | see footnotes | ||
| SERIES A PREFERRED STOCK | 0.0 | 2021-09-17 | deemed execution date | C | 393,940 (d) | common stock 1,023,219 | $0.00 | 0 | indirect | see footnotes | ||
| SERIES A PREFERRED STOCK | 0.0 | 2021-09-17 | deemed execution date | C | 170,448 (d) | common stock 442,721 | $0.00 | 0 | indirect | see footnotes | ||
| SERIES B PREFERRED STOCK | 0.0 | 2021-09-17 | deemed execution date | C | 546,773 (d) | common stock 1,420,188 | $0.00 | 0 | indirect | see footnotes | ||
| SERIES B PREFERRED STOCK | 0.0 | 2021-09-17 | deemed execution date | C | 182,257 (d) | common stock 473,394 | $0.00 | 0 | indirect | see footnotes |
| ID | footnote |
|---|---|
| f1 | on september 17, 2021, each share of series a preferred stock and each share of series b preferred stock converted into common stock of the issuer at a ratio of 1-for-2.5974 without payment of further consideration upon closing of the initial public offering of the issuer's common stock. the shares had no expiration date. |
| f2 | these securities are held directly by ra capital healthcare fund, l.p. (the "fund"). |
| f3 | these securities are held directly by ra capital nexus fund, l.p. (the "nexus fund"). |
| f4 | ra capital management, l.p. (the "adviser") is the investment manager for the fund, the nexus fund, and a separately managed account (the "account"). the general partner of the adviser is ra capital management gp, llc (the "adviser gp"), of which dr. peter kolchinsky and mr. rajeev shah are the managing members. the adviser, the adviser gp, dr. kolchinsky, and mr. shah disclaim beneficial ownership of any of the reported securities, except to the extent of their pecuniary interest therein. |
| f5 | these securities are held directly by the account. |
